Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus

NCT01603121 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Unable to enroll sufficient number of subjects

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Lisofylline

Sponsor

Eastern Virginia Medical School